The Statue of Liberty is pictured on Liberty Island in New York, October 13, 2013. REUTERS/Carlo Allegri/Files

Pfizer Inc. (NYSE:PFE) stock is presently standing at about $33.44 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 20 analysts covering the company is $38.00, which suggests the stock could still rise over 12 percent. The highest analyst price target is $53.00, which implies a rally of 42 percent. And a quick view of analyst notes show that 10 are rating the stock a buy while 1 rate PFE a strong buy. There are 11 equity research firms advocating a Hold and 0 consider it Sell.

Guggenheim analysts provided their view on Pfizer Inc. (NYSE:PFE) recently. The rating firm issued a Neutral rating to this company in a research note released on Dec 02, 2016. Argus analysts disclosed their opinion on Pfizer Inc. (NYSE:PFE) recently. The rating firm gave a Hold rating to this stock in a research note published on Nov 02, 2016. According to a research note disclosed on Oct 13, 2016, analysts at Jefferies have lowered their rating on these shares from Buy to Hold.

Pfizer Inc. (NYSE:PFE) Transactions Roundup

Several insiders were part of recent insider activity for the stock. Its Executive Vice President MADDALUNA ANTHONY J sold 10,000 company shares for $330000, in a transaction on 2016-11-09. Following the transaction, the Executive Vice President is left with a stake of 330 shares, currently valued at $11035. Meanwhile, Group President BOURLA ALBERT sold 18,390 shares worth $552000.62, through a transaction dated 2016-11-04. Following the completion of the transaction, the insider is left with a stake of 133,248 shares, amounting $4455813.12. PFE Executive Vice President DAMELIO FRANK A also sold 100,000 shares, at a stock price of $34.49. This transaction occurred on 2016-05-26 totals $3449000. After this transaction, the insider’s stake stands at 377,699 shares, with a market value of $12630255.

Executives hold 0.22 percent of the stock. Dr. Henry A. McKinnell,Jr,PhD is one of the biggest insider owners in Pfizer Inc. (NYSE:PFE), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 2,134,851 shares which have current market value of around $71389417.44.William C. Steere,Jr is another major inside shareholder in the company. The insider owns 1,265,131 shares as of less than 0.1%, currently worth $42305980.64. Ms. Karen Katen is ranked as third insider holder of the stock. This insider holds 941,284 shares with a market value around $31476536.96 as of recent close.

Pfizer Inc. (NYSE:PFE) Earnings Outlook

In Pfizer Inc. (NYSE:PFE)’s latest quarter, EPS moved to $0.61 from $0.64 in preceding quarter and revenues reached at $13,045.00M compared to $13,147.00M. Analysts had expected Pfizer Inc. (NYSE:PFE) to post net income of about $0.62 per share on $13,040.90M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $0.64 to $0.69. That is compared with the $0.53 in EPS it reported during the same period a year ago.